Delayed Prostate Cancer Therapy Riverhead NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

MOHAMMED HOSSAIN, MD
(631) 475-1684
130 Hospital Road
Patchogue, NY
SUSAN EMANUELE, MD
(631) 727-7100
1267 E Main Street
Riverhead, NY
Margie A Lewis, MD
631-474-6183
PO Box 2041
Miller Place, NY
Barry Leslie Strauss, MD
631-283-6611
353 Meeting House Ln
Southampton, NY
Alexander A Tocher, MD
595 Route 25a
Miller Place, NY
Vijay Shah
(718) 204-0414
444 W Main St
Patchogue, NY
LOUIS AVVENTO, MD
(631) 727-8827
1333 E Main Street
Riverhead, NY
BARRY STRAUSS, MD
(631) 283-6611
353 Meeting House Lane
Southampton, NY
Alexander I Zuhoski, MD
631-727-8500
1333 E Main St
Riverhead, NY
Douglas Edward Gladstone, MD
12 Sunwood Dr
Miller Place, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Breast Cancer Riverhead NY
Breast tenderness in women taking estrogen/progestin hormone replacement therapy could signal increased chances of developing breast cancer, a new study says. Women taking estrogen plus progestin who reported developing breast tenderness after starting the hormone therapy were 48 percent more likely to develop invasive breast cancer than women on hormone therapy who did not experience breast tenderness.
- Exercise for Prostate Cancer Riverhead NY
- Hormone Therapy for Early Prostate Cancer Riverhead NY
- Attack Of The Cancer Fighting Tomatoes Riverhead NY
- Drug Combo Proves Powerful Against Lung Cancer Riverhead NY
- Hormone Therapy for Prostate Cancer Riverhead NY
- Hormone Therapy for Lung Cancer Riverhead NY
- Diagnosis of Prostate Cancer Riverhead NY
- Open Prostatectomy Versus Laparoscopic Procedure Riverhead NY
- Head and Neck Cancer Treatment Riverhead NY